KindlyMD, Inc.

NAKA Financial Capital Markets

KindlyMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 million, down 33.0% from fiscal 2024.

Revenue
+8,680.7%
EPS
+52.5%
Free cash flow
−25.7%

Quarter to June 2026, against a year earlier

5.54 0.48 −7.97%
Market cap
$99.7M
P/E
0.0×
Fwd P/E
−0.3×
Dividend yield
—
F-score
3/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Insider Decisions last twelve months

Bought, $m 1.23
Sold, $m 0.01
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — 2 — — 2 — — —
Sell — — — — — — — — — 1 — —
Insider Ownership 45.85%

Capital & Financial Ratios $m

Size
Market Cap 99.68
Revenue ttm 39.79
Net income ttm (420.55)
Free cash flow ttm (687.94)
Net debt Q (19.07)
Valuation
P/E 0.00
Forward P/E (0.28) (negative: loss-making)
Price / sales 2.78
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.47
Financial health
Current ratio Q 0.15
Debt / equity Q 0.00
Interest coverage Q (37.12)
Growth
Revenue growth Q +8,680.66% (above 0%: growing)
Operating income growth Q −6,133.70% (below 0%: shrinking)
EPS, this year +23.94% (at or above 15%: strong)
EPS, next year A +86.89% (at or above 15%: strong)
Revenue, next year A +3,834.00% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A +62.35% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 1 2 23 19
Receivables 0 0 — —
Inventory 0 0 — —
Other — — 199 4
1 3 224 27
2023 2024 2025 Q'26
Payables 0 0 6 11
ST’ Debt — — — —
Other 0 0 1 4
1 1 216 179

Compound Annual Growth %

10y 5y 3y
Sales — — —
Cash Flow — — —
Earnings — — —
Book Value — — —

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 (15.20) (6.65) — — —
’25 (6.80) (14.00) (16.80) 2.80 (10.40)
’24 (2.40) (10.40) (6.80) (6.80) (26.80)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 3 36 — — —
’25 1 0 0 1 2
’24 1 1 1 1 3
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (23) (3) — — —
’25 (1) (2) (13) (8) (24)
’24 0 (1) (1) (1) (3)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (7) (5) — — —
’25 (1) (4) (655) (21) (679)
’24 0 (1) (1) (1) (3)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — — — — — 4 3 2 40 (30.5%) 72 66 67 +232.6%
Gross margin, % — — — — — — — 94.00 100.00 100.00 61.39 +6.0 pt
EBT — — — — — — — (2) (4) (52) (443) +468.2%
EBT margin, % — — — — — — — (42.92) (133.01) (2,867.67) (1,112.36) (2,824.7) pt
Net income — — — — — — — (2) (4) (52) (421) +468.2%
Per share, $
Per share, $ Revenue — — — — — — — 33.50 20.18 0.36 1.99 (89.6%)
Earnings — — — — — — — (14.38) (26.80) (10.40) (35.85) (14.9%)
Cash flow — — — — — — — (4.00) (22.80) (4.70) (2.36) +8.4%
Capex — — — — — — — (0.13) (2.98) (130.92) (32.03) +3,098.2%
Free cash flow — — — — — — — (4.12) (25.78) (135.62) (34.40) +473.5%
Book value — — — — — — — (0.96) 19.05 102.75 11.82 n/m
Shares, m — — — — — — — 0 0 5 11 +567.0%
Valuation, ×
Valuation, × P/E — — — — — — — 0.00 0.00 0.00 0.00 0.0
P/S — — — — — — — 4.06 2.46 31.51 2.78 12.7
P/B — — — — — — — 0.00 2.60 0.14 0.47 0.9
EV/Sales — — — — — — — 4.02 1.63 22.07 — 9.2
EV/FCF — — — — — — — (16.42) (1.27) (0.07) — (5.9)
Cash, $m
Cash, $m Operating cash flow — — — — — — — 0 (3) (24) (47) +623.2%
Capex — — — — — — — 0 0 (655) (641) +21,231.7%
Free cash flow — — — — — — — 0 (3) (679) (688) +3,725.2%
Balance, $m
Balance, $m Working capital — — — — — — — 0 2 8 (152) n/m
Net debt — — — — — — — 0 (2) (23) (19) +772.6%
Shareholders’ equity — — — — — — — 0 3 514 236 n/m
Returns, %
Returns, % ROA — — — — — — — 0.00 (151.45) (14.23) (194.52) (14.2) pt
ROIC — — — — — — — 0.00 (691.95) (25.06) (135.54) (25.1) pt
ROE — — — — — — — 0.00 (294.13) (20.21) (342.78) (20.2) pt
People
People Employees — — — — — — — — 61 65 — +6.6%
Revenue/emp, $m — — — — — — — 0.00 0.04 0.03 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

KindlyMD, Inc. vs peers in Capital Markets (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
FUFU BitFuFu Inc. $149.7M — (loss-making) — (loss-making) −62.94% (below 0%: shrinking) n/m +92.59% (above 0%: growing) (2.24%) (51.24%) Compare
AUC ATIF Holdings Limited $138.3M — (loss-making) — (loss-making) +275.00% (above 0%: growing) n/m −4,494.70% (below 0%: shrinking) 100.00% 29.15% Compare
DEFT DeFi Technologies Inc. $133.2M 5.7× — −40.69% (below 0%: shrinking) n/m −24.31% (below 0%: shrinking) 100.00% (22.78%) Compare
SLNH Soluna Holdings, Inc. $112.8M — (loss-making) — (loss-making) +144.56% (above 0%: growing) n/m −124.94% (below 0%: shrinking) 5.09% (112.50%) Compare
GSIW Garden Stage Limited $111.4M — — — — +38.83% (above 0%: growing) — — Compare
NAKA KindlyMD, Inc. $99.7M — (loss-making) — (loss-making) +8,680.66% (above 0%: growing) n/m −25.71% (below 0%: shrinking) 57.82% (415.62%)
WTF Waton Financial Limited $94.6M — — — — −161.72% (below 0%: shrinking) — — Compare
BMHL Bluemount Holdings Limited $86.5M — — — — −870.71% (below 0%: shrinking) — — Compare
SIEB Siebert Financial Corp. $76.9M — (loss-making) — (loss-making) +109.59% (above 0%: growing) n/m −1,855.09% (below 0%: shrinking) 97.24% (0.78%) Compare
Median of peers $112.1M — — +109.59% — −143.33% 97.24% (22.78%)

All 97 Capital Markets stocks →

Pay and ownership Proxy statement filed 29 October 2026

Ownership

Directors and executive officers, together 24.08%
David Bailey 17.63%
Calli Bailey 14.35%
Tyler Evans 6.50%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

KindlyMD, Inc. (NAKA) Latest News

15 Jul

Impact 4 · · TheStreet

24 Jun

23 Jun

10 Apr

Impact 4 · · cryptoprowl.com

18 Dec

12 Dec

Impact 4 · · coindesk.com

9 Dec

Impact 4 · · Bloomberg

21 Nov

Impact 3 · · blockspace.media

27 Oct

Impact 3 · · Associated Press Finance

24 Oct

Impact 3 · · Associated Press Finance

9 Oct

stockrow.com/NAKA · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com